利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN101754957A 新的杂环基化合物和它们作为趋化因子拮抗剂的用途 失效 - 放弃专利权

新的杂环基化合物和它们作为趋化因子拮抗剂的用途
摘要：
本发明涉及式(I)的新的杂环基化合物，，其中A、X、Y、R3、R4、R5、R6、R7、R8、R9、R10、m和n如说明书和权利要求中所定义，以及其生理可接受的盐。这些化合物是CCR2受体、CCR5受体和/或CCR3受体的拮抗剂，能用作药剂。
摘要（英）：

The invention is concerned with novel heterocyclyl compounds of formula (I), wherein A, X, Y, R3, R4, R5, R6, R7, R8, R9, R10, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.

0/0